Our group has previously demonstrated that oxidized phospholipids in mildly oxidized LDL (MM-LDL) Oxidation of LDL appears to play an important role in the development and progression of the atherosclerotic lesion (1 -3). Artery wall cells can produce oxidative species via multiple pathways which "seed" LDL trapped in the subendothelial space and initiate lipid oxidation (4-6). The biological properties of oxidized LDL in vitro appear to be dependent on the degree to which the lipid and protein components are oxidized.
Introduction
Our group has previously demonstrated that oxidized phospholipids in mildly oxidized LDL (MM-LDL) produced by oxidation with lipoxygenase, iron, or cocultures of artery wall cells increase monocyte-endothelial interactions and this sequence of events is blocked by HDL. To obtain further insight into the mechanism by which HDL abolishes the activity of MM-LDL we investigated the effect of the HDLassociated ester hydrolase paraoxonase (PON). Treatment of MM-LDL with purified PON significantly reduced the ability of MM-LDL to induce monocyte-endothelial interactions. Inactivation of PON by pretreating HDL with heat or EDTA reduced the ability of HDL to inhibit LDL modification. HPLC analysis of phospholipids isolated from MM-LDL before and after treatment with purified PON showed that the 270 nm absorbance of phospholipids was decreased, while no effect was observed on 235 nm absorbance. Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) and specific fractions of Ox-PAPC isolated by HPLC induced the same monocyte-endothelial interactions as did MM-LDL. Biologically active and inactive HPLC fractions of Ox-PAPC were compared by fast atom bombardment-mass spectrometry which revealed that active fractions possessed ions with a mass to change ratio greater than native PAPC by multiples of 16 D suggesting the addition of 3 and 4 oxygen atoms to PAPC. Comparison of Ox-PAPC by fast atom bombardment-mass spectrometry before and after PON treatment showed that PON destroyed these multi-oxygenated molecules found in biologically active fractions of Ox-PAPC. These results suggest 3) . Artery wall cells can produce oxidative species via multiple pathways which "seed" LDL trapped in the subendothelial space and initiate lipid oxidation (4) (5) (6) . The biological properties of oxidized LDL in vitro appear to be dependent on the degree to which the lipid and protein components are oxidized.
Mildly oxidized LDL (MM-LDL)' induces the activation of the nuclear transcription factor NFKB via a cAMP-dependent mechanism (7) and consequently induces endothelial cells to express monocyte-specific chemoattractants (8, 9) , adhesion molecules (10) , and colony stimulating factors (11) . Highly oxidized LDL (Ox-LDL) is cytotoxic to artery wall cells (12) (13) (14) and is taken up by the scavenger receptor on macrophages (15) (16) (17) . In humans, plasma levels of HDL are inversely correlated with the risk of clinically significant coronary events ( 18, 19) . Moreover, in vitro experiments have demonstrated that HDL inhibits LDL modification (9, 14, 20, 21) . Despite convincing evidence for the presence of oxidized LDL in the blood vessel wall (22) (23) (24) and the antiatherogenic properties of HDL, the interaction between these two lipoprotein particles is not well understood.
Human serum paraoxonase (PON) is a calcium-dependent HDL-associated ester hydrolase that catalyzes the hydrolysis of organophosphates, aromatic carboxylic acid esters, and carbamates (25) . The initial measurement of its activity was performed using synthetic substrates, therefore, an interesting, and as yet unresolved question, is what role PON plays in metabolizing substrates formed in vivo. PON is tightly associated with apolipoprotein A-I in HDL and has the highest activity in the liver and blood (25) . Serum PON levels vary widely between different animal species (26) and among humans (27) . Individuals with familial hypercholesterolemia and insulin-dependent diabetes mellitus have significantly lower serum levels of PON than do control individuals (28) . Low levels of HDL-associated esterases are also correlated with susceptibility to myocardial infarction, fish eye disease, and Tangier disease (29, 30) . HDLassociated PON has been reported to inhibit copper-induced lipid peroxide generation in LDL (31) . Our laboratory has recently shown that platelet activating factor-acetylhydrolase (PAF-AH), a phospholipase A2 that hydrolyzes short chain acyl groups and longer chain aldehydes esterified to the sn-2 position of phospholipids, plays an important role in modulating the biological activity of MM-LDL (32 (33) .
Endothelial cell cultures. Rabbit aortic endothelial cells (RAEC) at passages 9-17 and human aortic endothelial cells (HAEC) at passages 4-7 were cultured as described (9, 10) . Porcine aortic endothelial cells (PAEC) were isolated by enzymatic digestion according to the method of Rosenthal et al. (34) with described modifications (32) .
Cocultures. HAEC and human aortic smooth muscle cells (HASMC) were isolated and prepared as previously described (9, 32, 35) . Blood monocytes were obtained from a large pool of healthy donors using a modification of the Recalde procedure (36) .
Lipoprotein isolation and modification. LDL (d = 1.019-1.069 grams/ml) and HDL (d = 1.069-1.210 grams/ml) were isolated from the sera of normal blood donors by density gradient ultracentrifugation as described (37) and stored at 40C until use within 1-2 wk of isolation.
Lipoprotein concentration was expressed in terms of protein content throughout this report. Mildly oxidized LDL was produced either by dialysis at 5 mg protein/ml in 6 jM FeSO47 H20 for 48-72 h at room temperature, by incubation at 1 mg protein/ml with soybean lipoxygenase (SLO) bound to CNBr-activated Sepharose beads with linoleic acid (187 mM) in 1 ml PBS for 24 h at 37°C (32) , or by incubation with human endothelial/smooth muscle cell cocultures for 8-24 h at 37°C (9) . SLO was removed by centrifugation after oxidation had occurred. Oxidation was terminated by the addition of EDTA and BHT at 100 /iM and 0.3 mM, respectively. EDTA was excluded in experiments using PON. The concentration of bacterial endotoxin in medium containing each agonist was < 50 pg/ml (determined by chromogenic assay) which is 50-fold less than that required to induce monocyte binding to endothelial cells.
Lipid extraction. Lipids were extracted using a modification of the method of Bligh and Dyer (38) as described (32 Fast atom bombardment-mass spectrometry. Fast atom bombardment spectra were obtained with a VG ZAB-SE instrument (VG Analytical, Manchester, United Kingdom) using an 11/250 data system; an 8-kV acceleration potential; xenon bombarding gas at 8 kV and 1 mA; and the instrument set at a mass resolution of 1,000 (M/AM, 10% valley). Aliquots (1-2 tl) of lipid suspended in chloroform were applied to the static probe tip onto which had been placed 1-2 Il of mnitrobenzyl alcohol. Data were collected by scanning from mass to charge ratio (m/z) 1,000 to 400 and an average spectrum was produced from six to eight independent scans. The data were mass measured using cesium iodide ion clusters for calibration. The mass accuracies of authentic phospholipid standards under these conditions were typically less than ±0.5 D.
Electrospray mass spectrometry. Electrospray mass spectrometry was performed with a PE SCIEX API III Biomolecular Mass Analyzer (Perkin-Elmer Corp., Norwalk, CT). Total lipid extracts from the equivalent of 5 mg protein were separated by preparative HPLC and fractions were dried and resuspended in 1 ml of 50% acetonitrile 0.1% formic acid. Aliquots (20 Ml) were injected at a flow rate of 20 Il/min into the ion source of the mass spectrometer which was scanning from m/z 150 to 1,000 (step size of 0.1 D, scan speed of 5 s). Signals were mass measured by means of the multiply charged ion series from the separate introduction of polypropylene glycol for calibration. Under standard conditions the accuracy of these mass measurements is < ±0.05 D. Selected ion chromatograms were produced by software supplied by PE SCIEX.
Monocyte adhesion/transmigration assays. These studies were performed essentially as described previously (7, 9, 10, 32) . Briefly, for monocyte adhesion assays human aortic endothelial cells were incubated with test medium for 4 h at 37°C. A suspension of human monocytes were added for 15 min and nonadherent monocytes were removed. Bound monocytes were counted and expressed as monocytes/microscopic field. For monocyte transmigration studies, cocultures were treated with native LDL in the absence or presence of various test compounds for 8-24 h at 37°C. The coculture supernatants were subsequently transferred to untreated cocultures and incubated for an additional 24 h. Test medium was removed and human monocytes were added for 45-90 min at 37°C. Loosely adherent monocytes were removed and cocultures were fixed. Subendothelial monocytes were enumerated under a magnification of 625. Data were analyzed using model 1 ANOVA.
Enzyme activity assays. PAF-AH activity was determined by using 2-[acetyl-3H] PAF as a substrate. The [3H] -acetate generated after sn-2 hydrolysis was separated from labeled substrate by solid phase extraction chromatography and quantitated by liquid scintillation as described previously (40) . Enzymic activity is expressed in micromoles hydrolyzed/min per milligram protein after appropriate corrections. PON activity was determined using paraoxon as the substrate by measuring the increase in the absorbance at 412 nm due to formation of 4-nitrophenol. Activity was measured in 50 nM Tris/HCl buffers at pH 7.4 and 8.0, and in 50 nM glycine/NaOH at pH 10.5. The sample to be tested was added to start the reaction and the increase in absorbance at 412 nm was recorded (33) . The quantity of 4-nitrophenol formed was calculated from the molar extinction coefficients at pH 7. (Fig. 1 A) . Conversely, EDTA had no effect on the PAF-AH activity in HDL, but PMSF reduced PAF-AH activity by 60% (Fig. 1 B) . Fig. 1 Effect of paraoxonase on the biological activity of mildly oxidized-LDL. Mildly oxidized-LDL produced in vitro with oxidative enzymes (Fig. 2 A) or in vivo by incubation with cocultures (Fig. 2 B) was incubated with purified PON at 370C for 14 h. Regardless of the method used to produce MM-LDL, treatment with PON reduced the ability of MM-LDL to induce monocyte binding and transmigration. MM-LDL incubated in the presence of the buffer in which PON was suspended (but without PON) had no effect on monocyte adhesion induced by MM-LDL (Fig. 2 B) . Controls to which EDTA and PMSF were added in the absence of lipoproteins had no effect on LDL oxidation or biological activity. Similar results were obtained with PON isolated from human and rabbit plasma both of which produced a single band on polyacrylamide gel electrophoresis.
HPLC analysis ofmildly oxidized-LDL. Phospholipids from LDL were analyzed before and after modification by incubation for 24 h with cocultures of human artery wall cells. Phospholipids extracted from MM-LDL possessed increased UV absorbance at 270 nm compared to unoxidized LDL from the same donor (Fig. 3) . As noted before (32) , under these HPLC conditions phosphatidylcholine (PC) elutes as a bimodal peak (32) . Phospholipids were suspended in chloroform and analyzed by normal phase analytical HPLC while scanning UV absorbance between 200 and 350 nm with a diode array detector. Fig. 4 displays HPLC chromatograms of phospholipids from coculture modified LDL at 235 and 270 nm before and after incubation with PON at 370C for 14 h. Treatment of CM-LDL with PON had little effect on the 235 nm absorbance of phosphatidylcholine (Fig. 4 A) , however, PON treatment greatly reduced the 270 nm-absorbing material associated with CM-LDL phosphatidylcholine (Fig. 4  B) . These results indicate that PON may selectively recognize Biological activity of oxidized synthetic phospholipids. As described above, mild oxidation of LDL appears to decrease the abundance of arachidonic acid-containing phospholipids in LDL. We, therefore, tested the ability of oxidized PAPC (Ox-PAPC) to induce endothelial cells to bind monocytes. HPLC analysis of Ox-PAPC revealed the presence of 235 nm absorbing material eluting at 7.0 min (data not shown), a variety of 270 nm absorbing species eluting between 7.0 and 13.0 min, and the presence of residual unoxidized PAPC (200 nm) eluting at 8.0 min (Fig. 5 A) . Under these HPLC conditions unoxidized PAPC did not absorb at a wavelength greater than 223 nm and was not active in increasing monocyte binding (data not shown). HPLC fractions were collected from Ox-PAPC under sterile conditions and tested individually for the ability to induce endothelial cells to bind monocytes (Fig. 5 B) . Fractions 11 and 12 induced a significant increase in monocyte binding, however, fraction 7 which contained predominately 235 nm absorbing material and fraction 8 which contained predominately unoxidized PAPC did not cause a significant increase in monocyte binding to endothelial cells (Fig. 5 B) . A comparison of frac- Effect ofparaoxonase on oxidized-PAPC. Ox-PAPC (1 mg) was resuspended in 1 ml of PBS containing 1 mM calcium and divided into two equal portions. One portion was treated as a sham and the other portion was incubated with PON (5 tg/ml) at 37°C for 14 h. The sham treated Ox-PAPC induced a significant increase in monocyte binding to endothelial cells, however, the same preparation after treatment with PON was without biological activity (Fig. 6 A, P < 0.001). Phospholipids treated under the same conditions were extracted and analyzed by FAB-MS. Unoxidized PAPC (Fig. 6 B) sented M + H + + 48.0 and M + H + + 64.0, due to the addition of three and four oxygen atoms, respectively, to PAPC. After treatment with PON (5 Mtg/ml) for 14 h at 370C the higher molecular weight ions were completely absent (Fig. 6 D) . These results indicated that paraoxonase destroyed phospholipids containing multioxygenated PUFA. Mass spectrometry ofMM-LDL. Lipids were extracted from coculture modified LDL and native LDL from the same donor and analyzed by preparative HPLC. Three fractions were collected that encompassed the region of biological activity evident in Fig. 5 . Fraction 2 contained -80% of the biological activity (i.e., induction of monocyte binding) (data not shown). Each fraction was resuspended in 1 ml of solvent and 20 pl was injected sequentially into an electrospray mass spectrometer. Reconstructed selected ion monitoring was then conducted to determine the relative abundance of ions with m/z 831 and 847. The signal from each fraction (1 through 3) in N-LDL (Fig. 5  A) were subtracted from respective fractions in MM-LDL (Fig.  5 B) and the differential chromatogram shown in Fig. 5 C (MM-LDL minus N-LDL). The total abundance of these ions in the fractions from MM-LDL (Fig. 5 B) was approximately three times that seen in native LDL (Fig. 5 A) . The ion with m/z 831 showed a distribution that paralleled the biological activity in the three fractions. The ion with m/z 847 was present in approximately equal abundance in fractions 1 and 2. Since the biological activity of fraction 1 was less than that of fraction 2, the data suggest that most of the biological activity may have been associated with the ion with m/z 831 that eluted in fraction 2. Similar results were obtained from analysis for oxidized arachidonic acid-containing phospholipids with stearic acid at the sn-i position (data not shown). These data, taken together, strongly suggest that oxygenated phospholipids contribute to the biological activity of MM-LDL.
Discussion
This manuscript is the first publication to document an effect of paraoxonase on biologically active lipids in oxidatively modi- (Fig. 7) . The molecular mass of these phospholipids are consistent with nonenzymatically formed, arachidonic acid-derived, eicosanoids at the sn-2 position of PAPC. Most of these eicosanoids possess absorbance maxima in the 265-290 nm range, however the precise molecular structure of the molecules present in our FAB-MS spectra has not yet been determined. An example of this phenomenon is phospholipid-bound F2-isoprostanes (m/z 831) which have been shown to be present in oxidized LDL (43). Isoprostanes have also been shown to possess biological activity on smooth muscle cells (44, 45) . Initial studies in our laboratory suggest that the free-acid form is active in inducing monocyte binding to human aortic endothelial cells (data not shown).
The mechanism by which PON protects against the action of MM-LDL appears to be associated with destruction of oxidized phospholipids in MM-LDL. PON destroyed multioxygenated PAPC molecules (Fig. 6 D) in Ox-PAPC and decreased the amount of 270 nm absorbance of phospholipids in MM-LDL (Fig. 4) . To account for both of these observations we would hypothesize that the substrate for PON is an arachidonic acidcontaining phospholipid to which three to four oxygens have been added in an orientation that alters the spectral absorbance of the molecule. The presence of 270 nm absorbance may be the result of the formation of carbonyl groups or the addition of hydroxyl or hydroperoxyl groups at the 5 and 12 carbons of arachidonic acid forming a conjugated triene structure characteristic of leukotrienes. Any of these compounds may decompose to form short chain acyl residues at the sn-2 position such as 5-oxovalerate which have been shown to be biologically active (46) and are substrates for PAF-AH (47, 48 The current and past (32) studies from our group suggest that both PAF-AH and paraoxonase can destroy active lipids in MM-LDL and that their effects are additive. Several lines of evidence suggest that there are differences in the action of the two enzymes. In addition, during copper-induced oxidation of LDL, PAF-AH inhibits apolipoprotein Bloo modification and conjugated diene formation but has no effect on thiobarbituric acid reactive substances (TBARS) (reference 49 S. M., personal communication) however, PON inhibits both the production of lipoperoxides and TBARS (31) . Treatment of MM-LDL with PAF-AH resulted in a decrease in 234 nm absorbance (reference 32, Fig. 5 ), while PON had no effect on 234 nm absorbance but resulted in a decrease in 270 nm absorbance (Fig. 4) . Furthermore, PAF-AH has been shown to act on molecules with nine carbons or less at the sn-2 position (46) while PON has been shown in the current study to act on derivatives with longer chains.
The experiments shown in Fig. 1 14 h also reduced the ability of the MM-LDL to induce monocyte-endothelial interactions but shorter coincubation times of HDL with MM-LDL (< 6 h) like those used previously (9) were not sufficient to destroy the biological activity (data not shown). We previously reported (9) that phospholipid liposomes (but not purified apo Al) prevented the biological activity of coculture modified LDL. Since these liposomes did not contain either PON or PAF-AH before addition to the cocultures the possibility exists that these liposomes served as a sink for the biologically active lipids of the kind shown in Fig. 8 . These lipids may have been sequestered in the liposomes in such as way as to prevent their interaction with the coculture cells in a manner necessary to trigger the expression of the genes that induce monocyte binding and migration. The protective effect of HDL may not be dependent on the absolute levels of HDL cholesterol in the blood but rather the abundance of HDL particles which contain protective enzymes relative to the concentration of oxidized LDL proximate to the artery wall cells. This ratio is determined by both genetic and environmental factors. Genetic determinants may include plasma levels and isoforms of PON and PAF-AH. Environmental influences may include factors that augment the accumulation of LDL in the subendothelial space (e.g., hypercholesterolemia and apolipoprotein [a]) as well as factors which increase oxidative stress (e.g., smoking and diabetes). The findings presented herein could, in part, help to explain why some individuals with low LDL/HDL ratios experience clinical events while other individuals with high LDL/HDL ratios live free from clinical events resulting from vascular disease.
